SCH-50911
CH-50911 is a selective GABA-B antagonist with IC50 value of 1.1 μM. It is developed by Schering-Plough Corporation. CH-50911 is often used in pharmacology research and it also acts as an anticonvulsant under normal conditions. Preclinical trials for Absence seizures and Cognition disorders in USA were discontinued.
| Supplier | BOC Sciences |
|---|---|
| Product # | 733717-87-8 |
| Pricing | Inquire |
| Cas | 733717-87-8 |
| Molecular Weight | 173.21 |
| Molecular Formula | C8H15NO3 |
| Canonical SMILES | CC1(CO[C@H](CN1)CC(=O)O)C |